BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 32972504)

  • 1. Value of Preoperative Neutrophil-to-Lymphocyte Ratio in Predicting Prognosis of Surgically Resectable Urinary Cancers: Systematic Review and Meta-Analysis.
    Wang Z; Wang X; Wang WD; Zheng GY; Guo H; Zhang YS
    Chin Med Sci J; 2020 Sep; 35(3):262-271. PubMed ID: 32972504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preoperative neutrophil-lymphocyte ratio can significantly predict mortality outcomes in patients with non-muscle invasive bladder cancer undergoing transurethral resection of bladder tumor.
    Kang M; Jeong CW; Kwak C; Kim HH; Ku JH
    Oncotarget; 2017 Feb; 8(8):12891-12901. PubMed ID: 28039452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pretreatment Neutrophil-Lymphocyte Ratio as a Predictor in Bladder Cancer and Metastatic or Unresectable Urothelial Carcinoma Patients: a Pooled Analysis of Comparative Studies.
    Wu S; Zhao X; Wang Y; Zhong Z; Zhang L; Cao J; Ai K; Xu R
    Cell Physiol Biochem; 2018; 46(4):1352-1364. PubMed ID: 29689562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic role of NLR in urinary cancers: a meta-analysis.
    Wei Y; Jiang YZ; Qian WH
    PLoS One; 2014; 9(3):e92079. PubMed ID: 24642859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of preoperative lymphocyte-related systemic inflammatory biomarkers in upper tract urothelial carcinoma patients treated with radical nephroureterectomy: a systematic review and meta-analysis.
    Shao Y; Li W; Wang D; Wu B
    World J Surg Oncol; 2020 Oct; 18(1):273. PubMed ID: 33097052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pre-treatment neutrophil-to-lymphocyte ratio as predictor of adverse outcomes in patients undergoing radical cystectomy for urothelial carcinoma of the bladder.
    Hermanns T; Bhindi B; Wei Y; Yu J; Noon AP; Richard PO; Bhatt JR; Almatar A; Jewett MA; Fleshner NE; Zlotta AR; Templeton AJ; Kulkarni GS
    Br J Cancer; 2014 Jul; 111(3):444-51. PubMed ID: 24918819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of pretreatment neutrophil-to-lymphocyte ratio in renal cell carcinoma: a systematic review and meta-analysis.
    Shao Y; Wu B; Jia W; Zhang Z; Chen Q; Wang D
    BMC Urol; 2020 Jul; 20(1):90. PubMed ID: 32631294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical significance of prognosis using the neutrophil-lymphocyte ratio and erythrocyte sedimentation rate in patients undergoing radical nephroureterectomy for upper urinary tract urothelial carcinoma.
    Sung HH; Jeon HG; Jeong BC; Seo SI; Jeon SS; Choi HY; Lee HM
    BJU Int; 2015 Apr; 115(4):587-94. PubMed ID: 24947340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is neutrophil-to-lymphocytes ratio a clinical relevant preoperative biomarker in upper tract urothelial carcinoma? A meta-analysis of 4385 patients.
    Vartolomei MD; Kimura S; Ferro M; Vartolomei L; Foerster B; Abufaraj M; Shariat SF
    World J Urol; 2018 Jul; 36(7):1019-1029. PubMed ID: 29468284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The clinical use of neutrophil-to-lymphocyte ratio in bladder cancer patients: a systematic review and meta-analysis.
    Tang X; Du P; Yang Y
    Int J Clin Oncol; 2017 Oct; 22(5):817-825. PubMed ID: 28752351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic role of neutrophil-to-lymphocyte ratio (NLR) in urological tumors: an umbrella review of evidence from systematic reviews and meta-analyses.
    Mjaess G; Chebel R; Karam A; Moussa I; Pretot D; Abi Tayeh G; Sarkis J; Semaan A; Peltier A; Aoun F; Albisinni S; Roumeguère T
    Acta Oncol; 2021 Jun; 60(6):704-713. PubMed ID: 33586577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neutrophil-to-lymphocyte ratio as prognostic indicator in gastrointestinal cancers: a systematic review and meta-analysis.
    Bowen RC; Little NAB; Harmer JR; Ma J; Mirabelli LG; Roller KD; Breivik AM; Signor E; Miller AB; Khong HT
    Oncotarget; 2017 May; 8(19):32171-32189. PubMed ID: 28418870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prognostic significance of controlling nutritional status (CONUT) score for surgically treated renal cell cancer and upper urinary tract urothelial cancer: a systematic review and meta-analysis.
    Peng L; Meng C; Li J; You C; Du Y; Xiong W; Xia Z; Cao D; Li Y
    Eur J Clin Nutr; 2022 Jun; 76(6):801-810. PubMed ID: 34815539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of systemic immune-inflammation index in patients with urinary system cancers: a meta-analysis.
    Wang Q; Zhu SR; Huang XP; Liu XQ; Liu JB; Tian G
    Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1302-1310. PubMed ID: 33629300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased Preoperative Serum AGR as a Diagnostic Marker of Poor Prognosis after Radical Surgery of Upper Urinary Tract and Bladder Cancers from a Pooled Analysis of 9,002 Patients.
    Wang X; Yang G; Chai Y; Li Z; Che X; Wang Y; Yang L; Zhou Z
    Dis Markers; 2022; 2022():6575605. PubMed ID: 36105255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Neutrophil-to-lymphocyte Ratio as a Prognostic Factor for Patients with Urothelial Carcinoma of the Bladder Following Radical Cystectomy: Validation and Meta-analysis.
    Lucca I; Jichlinski P; Shariat SF; Rouprêt M; Rieken M; Kluth LA; Rink M; Mathieu R; Mbeutcha A; Maj-Hes A; Fajkovic H; Briganti A; Seitz C; Karakiewicz PI; de Martino M; Lotan Y; Babjuk M; Klatte T
    Eur Urol Focus; 2016 Apr; 2(1):79-85. PubMed ID: 28723455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neutrophil-to-Lymphocyte Ratio as a Prognostic Biomarker for Patients With Metastatic Renal Cell Carcinoma Treated With Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis.
    Chen X; Meng F; Jiang R
    Front Oncol; 2021; 11():746976. PubMed ID: 34900692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prognostic value of preoperative neutrophil-to-lymphocyte ratio in patients with upper tract urothelial carcinoma.
    Tan P; Xu H; Liu L; Ai J; Xu H; Jiang Y; Zhang X; Yang L; Wei Q
    Clin Chim Acta; 2018 Oct; 485():26-32. PubMed ID: 29908941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neutrophil-to-lymphocyte ratio predicts progression and recurrence of non-muscle-invasive bladder cancer.
    Mano R; Baniel J; Shoshany O; Margel D; Bar-On T; Nativ O; Rubinstein J; Halachmi S
    Urol Oncol; 2015 Feb; 33(2):67.e1-7. PubMed ID: 25060672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic role of neutrophil-to-lymphocyte ratio in head and neck cancer: A meta-analysis.
    Takenaka Y; Oya R; Kitamiura T; Ashida N; Shimizu K; Takemura K; Yamamoto Y; Uno A
    Head Neck; 2018 Mar; 40(3):647-655. PubMed ID: 29076207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.